Yingwen Zhang
Wuhan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
LncPRESS1 promotes the progression and cisplatin resistance of breast cancer through upregulation of ENO1 and activation of glycolysis.
Journal: Cell division
Published: July 01, 2025
Yiai Fuzheng decoction inhibits triple-negative breast cancer by remodeling the immune microenvironment.
Journal: Frontiers in immunology
Published: April 21, 2025
Author Correction: Compound Opening Arrow Mixture exerts anti-tumor effects in a mouse model of breast cancer.
Journal: Scientific reports
Published: November 15, 2022
Bioactive constituents of animal-derived traditional Chinese medicinal materials for breast cancer: opportunities and challenges.
Journal: Journal of Zhejiang University. Science. B
Published: July 06, 2022
The effect of pterostilbene and its active ingredients on experimental pulmonary fibrosis in asthma: a meta-analysis.
Journal: Postepy dermatologii i alergologii
Published: June 03, 2021
Pterostilbene alleviates pulmonary fibrosis by regulating ASIC2.
Journal: Chinese medicine
Published: April 14, 2021
Effect of weimaining on apoptosis and Caspase-3 expression in a breast cancer mouse model.
Journal: Journal of ethnopharmacology
Published: July 07, 2020
Compound Opening Arrow Mixture exerts anti-tumor effects in a mouse model of breast cancer.
Journal: Scientific reports
Published: March 05, 2019
Niu-Huang-Shen suppresses hepatocellular carcinoma cell growth and metastasis by regulating Yap1 expression.
Journal: Experimental and therapeutic medicine
Published: October 20, 2016
Showing 1-10 of 10
Last Updated: 09/26/2026